A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)

Cancer Clinical Trial

Official title:

A Geriatric Assessment Electronic Platform for Older Patients With Cancer (eGAP - Electronic Geriatric Assessment Platform)

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT04824859
• Other study ID #: UCCS21026
• Status: Terminated
• Phase: N/A
• Start date: December 7, 2021
• Est. completion date: April 30, 2023

Study information

• Verified date: March 2024
• Source: University of Rochester
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project assesses the feasibility and usability of the geriatric assessment platform (electronic Geriatric Assessment Platform or eGAP in 50 older patients with cancer, their caregivers, and their oncology team. Using an iterative process, we will refine the eGAP based on input from stakeholders.

Description:

A geriatric assessment is a multidisciplinary diagnostic process that can detect medical, psychosocial and functional problems not identified by routine evaluation. This can subsequently guide management of the identified problems. However, the time and resources required to incorporate a geriatric assessment into clinic visits remain the primary barriers for implementation. There is a need to increase the adoption of the geriatric assessment among general oncologists and to address the associated resource limitations. Our long-term goal is to utilize an electronic platform to facilitate completion of the geriatric assessment. This project assesses the feasibility and usability of the geriatric assessment platform (electronic Geriatric Assessment Platform or eGAP) in 50 older patients with cancer, their caregivers, and oncology providers. Using an iterative process, we will refine the eGAP based on input from stakeholders (patients, caregivers, oncologists, nurses, advanced practitioners)

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 15
• Est. completion date: April 30, 2023
• Est. primary completion date: April 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria for patients:

• Age =65 years

• Have a diagnosis of cancer

• Able to provide informed consent

• English-speaking (because the platform is currently in English)

Inclusion criteria for caregivers:

• Age =21 years

• Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters".

• Able to provide informed consent

• English-speaking

Inclusion criteria for oncologists:

• Oncologists, APPs, and nurses who care for the patient

Exclusion Criteria:

• N/A

Related Conditions & MeSH terms

• Cancer

Intervention

Behavioral:
• Behavioral
eGAP that allows patients to complete validated questionnaires, and these questionnaires will be summarized and recommendations provided to the treating team

Locations

Country	Name	City	State
United States	University of Rochester	Rochester	New York

Sponsors (1)

Lead Sponsor	Collaborator
University of Rochester

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility Retention Rate	Percentage of patients completing the assessments that are assigned to them on eGAP	1 week
Secondary	Recruitment rates	Percentage of patients who are approached and agree to enroll	1 week
Secondary	Self-Report Completion Time	Time spent on completing the self-reported assessments on the eGAP	1 week
Secondary	System Usability Scale	For patients, caregivers, and oncology providers: score on 10-item scale, ranging 0-100; higher score corresponds to greater usability	1 week